BNP Blood Levels Predict Heart Function and Survival After Heart Attacks
Brain natriuretic peptide (BNP) increases more proportionally than ANP after heart attacks and may be a better predictor of left ventricular function and long-term survival.
Quick Facts
What This Study Found
Plasma BNP may increase proportionally more than ANP after acute myocardial infarction and chronic heart failure, potentially offering superior diagnostic and prognostic value.
Key Numbers
How They Did This
Cohort study comparing plasma BNP, ANP, and N-terminal proANP as indicators of left ventricular systolic function and predictors of long-term survival in patients after acute myocardial infarction.
Why This Research Matters
Identifying the best blood biomarker for heart function after a heart attack helps clinicians make better treatment decisions and predict which patients are at highest risk.
The Bigger Picture
This study contributed to establishing BNP as the preferred natriuretic peptide marker in cardiology. BNP and NT-proBNP testing is now standard of care after heart attacks worldwide.
What This Study Doesn't Tell Us
Cohort study design; details of sample size and follow-up duration not specified in abstract. Comparison methodology may vary from modern assay standards.
Questions This Raises
- ?What BNP threshold levels best predict poor outcomes after myocardial infarction?
- ?Can serial BNP measurements guide treatment decisions after heart attacks?
Trust & Context
- Key Stat:
- BNP rises more proportionally BNP may increase proportionally more than ANP after heart attacks, making it a potentially superior biomarker
- Evidence Grade:
- Moderate clinical evidence from a cohort study with prognostic outcomes. Contributes to the evidence base for BNP superiority over ANP as a cardiac marker.
- Study Age:
- Published in 1996, this study contributed to the evidence that eventually made BNP/NT-proBNP the standard cardiac biomarker worldwide.
- Original Title:
- Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.
- Published In:
- Circulation, 93(11), 1963-9 (1996)
- Authors:
- Omland, T, Aakvaag, A(2), Bonarjee, V V, Caidahl, K, Lie, R T, Nilsen, D W, Sundsfjord, J A, Dickstein, K
- Database ID:
- RPEP-00375
Evidence Hierarchy
Frequently Asked Questions
What is BNP?
Brain natriuretic peptide (BNP) is a hormone released by the heart when it's stretched or stressed. Higher blood levels indicate the heart is under more strain, making BNP a reliable marker for heart failure and cardiac damage.
How is BNP used after a heart attack?
Doctors measure BNP in the blood to assess how much heart damage occurred, evaluate heart pumping function, and predict long-term outcomes. Higher BNP levels indicate more severe damage and worse prognosis.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00375APA
Omland, T; Aakvaag, A; Bonarjee, V V; Caidahl, K; Lie, R T; Nilsen, D W; Sundsfjord, J A; Dickstein, K. (1996). Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.. Circulation, 93(11), 1963-9.
MLA
Omland, T, et al. "Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.." Circulation, 1996.
RethinkPeptides
RethinkPeptides Research Database. "Plasma brain natriuretic peptide as an indicator of left ven..." RPEP-00375. Retrieved from https://rethinkpeptides.com/research/omland-1996-plasma-brain-natriuretic-peptide
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.